Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Industry Condemns Invasion Of Ukraine, Gives Details Of Pharma Firms’ Donations

Executive Summary

R&D-based pharma firms and European parallel traders are contributing to the emergency relief effort in Ukraine and to the refugee crisis by making financial donations to humanitarian organizations or sending medicines and other medical supplies directly to Ukraine.

You may also be interested in...



The Challenging Logistics Of Sending Medicine Donations To Ukraine

Parallel trading companies, which traditionally move medicines from low-priced to higher-priced markets across the EU, are getting involved in organizing donations of medical products to Ukraine.

The Challenging Logistics Of Sending Medicine Donations To Ukraine

Parallel trading companies, which traditionally move medicines from low-priced to higher-priced markets across the EU, are getting involved in organizing donations of medical products to Ukraine.

Europe's Generics Industry Takes Action To Maintain Medicines Access In Ukraine

Efforts are being made across the European off-patent community to bolster the supply chain and ensure access to medicines in Ukraine, says the generics and biosimilars industry association, Medicines for Europe. It has urged the EU to take a leading role in coordinating supplies through the new emergency response body, HERA.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS145799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel